NCT04531033View on ClinicalTrials.gov

Does Daily Supplementation of Lactobacillus Acidophilus MPH734, for One Week, Affect Acute (Immediate), Subacute (7 Days), and Post-treatment Discontinuation Lactose Metabolism, Gastrointestinal Symptoms, and Clinical Markers of Inflammation and Safety Compared to a Placebo

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 25, 2020

Primary Completion Date

August 25, 2021

Study Completion Date

November 14, 2022

Conditions

Lactose Intolerance

Interventions

DIETARY_SUPPLEMENT

Lactobacillus acidophilus MPH734

After supplementing with oral probiotics, it has been suggested that select probiotics capable of expressing Beta-glucosidase enzyme activity may likewise be effective treatment for lactose intolerance.

DIETARY_SUPPLEMENT

Placebo

placebo made to match dietary supplement being tested.

Trial Locations (1)

76513

University of Mary Hardin-Baylor, Belton